Internal Medicine, Hematology & Oncology · Clinton, MD
NPI
1306097209
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
8926 Woodyard Rd Ste 201
Clinton, MD, 20735
Phone (301) 868-7911
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.5M
233,651 services
Medicare patients, 2024
954
Average age 75
Drug cost, 2024
$3.6M
1,111 prescriptions
Company payments, 2025
$5,309
From 45 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jun F Sun was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 49,100 times for 77 patients. In total Jun F Sun billed 233,651 services in 173 codes, and Medicare paid $3.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-08-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 49,100 | 77 | $2.29 | $113K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 18,540 | 13 | $39.35 | $730K |
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 15,000 | 13 | $0.82 | $12K |
| J0185 Injection, aprepitant, 1 mg | Office | 12,480 | 22 | $1.33 | $17K |
| J0897 Injection, denosumab, 1 mg | Office | 7,980 | 50 | $20.45 | $163K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 7,600 | 15 | $44.72 | $340K |
| J9267 Injection, paclitaxel, 1 mg | Office | 6,870 | 17 | $0.08 | $565 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 6,700 | 59 | $15.34 | $103K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 5,320 | 12 | $36.83 | $196K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,538 | 103 | $0.09 | $320 |
| 85025 Blood Count | Office | 2,223 | 501 | $7.60 | $17K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,570 | 39 | $0.73 | $1,145 |
| 82784 Immunoassay | Office | 1,413 | 187 | $9.11 | $13K |
| 80053 Clinical Chemistry | Office | 1,163 | 334 | $10.34 | $12K |
| 99214 Office E&M - Established | Office | 992 | 456 | $111.72 | $111K |
By year: 2022 $3.9M for 381,201 services; 2023 $3.9M for 334,733 services; 2024 $3.5M for 233,651 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,223 | 501 | $7.60 | $17K |
| 82784 Immunoassay | 1,413 | 187 | $9.11 | $13K |
| 80053 Clinical Chemistry | 1,163 | 334 | $10.34 | $12K |
| 82728 Clinical Chemistry | 725 | 299 | $13.35 | $9,676 |
| 83550 Clinical Chemistry | 714 | 297 | $8.56 | $6,113 |
| 83540 Clinical Chemistry | 713 | 297 | $6.33 | $4,516 |
| 83520 Immunoassay | 425 | 170 | $16.92 | $7,191 |
| 36415 Venipuncture Blood Collection | 383 | 196 | $8.63 | $3,304 |
| 80048 Clinical Chemistry | 214 | 107 | $8.29 | $1,774 |
| 82378 Clinical Chemistry | 104 | 43 | $18.58 | $1,932 |
Medicare prescription drug claims, 2024
In 2024, the drug Jun F Sun prescribed most often to Medicare patients was Eliquis (Apixaban), with 224 prescriptions and refills. In total Jun F Sun wrote 1,111 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 224 | 332 | 45 | $187K |
| Warfarin Sodium Generic | 59 | 115 | 13 | $372 |
| Oxycodone Hcl Generic | 47 | 47 | 15 | $1,235 |
| Lenalidomide Generic | 46 | 47 | Under 11 | $537K |
| Pomalyst Pomalidomide | 39 | 39 | Under 11 | $894K |
| Xarelto Rivaroxaban | 38 | 83 | 14 | $47K |
| Fondaparinux Sodium Generic | 36 | 40 | Under 11 | $64K |
| Anastrozole Generic | 32 | 78 | 11 | $368 |
| Acyclovir Generic | 31 | 69 | 12 | $932 |
| Exemestane Generic | 30 | 46 | Under 11 | $4,331 |
| Potassium Chloride Generic | 27 | 34 | 13 | $146 |
| Dexamethasone Generic | 26 | 26 | Under 11 | $330 |
| Letrozole Generic | 25 | 71 | 11 | $898 |
| Allopurinol Generic | 23 | 41 | Under 11 | $539 |
| Ondansetron Hcl Generic | 20 | 20 | Under 11 | $198 |
Brand drugs: 431 claims; generic drugs: 680 claims; opioid claims: 88.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jun F Sun $5,309 ($5,309 in general payments such as food, travel and fees) from 45 companies. The largest payer was Karyopharm Therapeutics Inc. with $2,649.
| Company | Payments | Amount |
|---|---|---|
| Karyopharm Therapeutics Inc. KPTI | 4 | $2,649 |
| Pfizer Inc. PFE | 12 | $332 |
| Merck Sharp & Dohme LLC MRK | 11 | $256 |
| Janssen Biotech, Inc. JNJ | 10 | $197 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $165 |
| Genentech USA, Inc. ROG.SW | 5 | $133 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $126 |
| Daiichi Sankyo Inc. 4568.T | 4 | $112 |
| Stemline Therapeutics Inc. | 4 | $110 |
| Abbvie Inc. ABBV | 4 | $102 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.